OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37 | -39.3% | 11,881 | 0.0% | 0.00% | – |
| Q2 2023 | $61 | +7.0% | 11,881 | +10.6% | 0.00% | – |
| Q1 2023 | $57 | +62.9% | 10,744 | -13.1% | 0.00% | – |
| Q4 2022 | $35 | -99.9% | 12,360 | 0.0% | 0.00% | – |
| Q3 2022 | $51,000 | +4.1% | 12,360 | +1.6% | 0.00% | – |
| Q2 2022 | $49,000 | -21.0% | 12,164 | -2.8% | 0.00% | – |
| Q1 2022 | $62,000 | -67.0% | 12,519 | -53.7% | 0.00% | -100.0% |
| Q4 2021 | $188,000 | +36.2% | 27,064 | +96.3% | 0.00% | 0.0% |
| Q3 2021 | $138,000 | -32.7% | 13,785 | -4.8% | 0.00% | -50.0% |
| Q2 2021 | $205,000 | +21.3% | 14,475 | +40.9% | 0.00% | -66.7% |
| Q1 2021 | $169,000 | -23.5% | 10,272 | -3.7% | 0.01% | -25.0% |
| Q4 2020 | $221,000 | – | 10,662 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |